Targeted binding agents directed to uPAR and uses thereof

Details for Australian Patent Application No. 2007238809 (hide)

Owner AstraZeneca AB

Inventors Emery, Stephen Charles; Zhao, Qing; Elvin, Paul

Agent Davies Collison Cave

Pub. Number AU-A-2007238809

PCT Pub. Number WO2007/120693

Priority 60/790,642 10.04.06 US

Filing date 9 April 2007

Wipo publication date 25 October 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120693 Priority application(s): WO2007/120693

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238816-Methods for modulating formation and progression of cellulite

2007238808-Methods of killing and inhibiting the growth of ammonia-oxidising bacteria in tanks or containers of water